These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 34067783

  • 1. Role of Biomolecules in Osteoclasts and Their Therapeutic Potential for Osteoporosis.
    Zhao X, Patil S, Xu F, Lin X, Qian A.
    Biomolecules; 2021 May 17; 11(5):. PubMed ID: 34067783
    [Abstract] [Full Text] [Related]

  • 2. The Development of Molecular Biology of Osteoporosis.
    Gao Y, Patil S, Jia J.
    Int J Mol Sci; 2021 Jul 30; 22(15):. PubMed ID: 34360948
    [Abstract] [Full Text] [Related]

  • 3. The dietary anthocyanin delphinidin prevents bone resorption by inhibiting Rankl-induced differentiation of osteoclasts in a medaka (Oryzias latipes) model of osteoporosis.
    Imangali N, Phan QT, Mahady G, Winkler C.
    J Fish Biol; 2021 Apr 30; 98(4):1018-1030. PubMed ID: 32155282
    [Abstract] [Full Text] [Related]

  • 4. Sanggenon C Stimulates Osteoblastic Proliferation and Differentiation, Inhibits Osteoclastic Resorption, and Ameliorates Prednisone-Induced Osteoporosis in Zebrafish Model.
    Wang H, Feng T, Guo D, Zhang M, Chen L, Zhou Y.
    Molecules; 2018 Sep 13; 23(9):. PubMed ID: 30217005
    [Abstract] [Full Text] [Related]

  • 5. Cistanche deserticola polysaccharide attenuates osteoclastogenesis and bone resorption via inhibiting RANKL signaling and reactive oxygen species production.
    Song D, Cao Z, Liu Z, Tickner J, Qiu H, Wang C, Chen K, Wang Z, Dong S, Xu J.
    J Cell Physiol; 2018 Dec 13; 233(12):9674-9684. PubMed ID: 29968926
    [Abstract] [Full Text] [Related]

  • 6. Modulating osteoclasts with nanoparticles: A path for osteoporosis management?
    Rouco H, García-García P, Briffault E, Diaz-Rodriguez P.
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Dec 13; 15(4):e1885. PubMed ID: 37037204
    [Abstract] [Full Text] [Related]

  • 7. Low‑molecular weight fucoidan inhibits the differentiation of osteoclasts and reduces osteoporosis in ovariectomized rats.
    Jin X, Zhu L, Li X, Jia J, Zhang Y, Sun X, Ma J, Liu Z, Ma X.
    Mol Med Rep; 2017 Feb 13; 15(2):890-898. PubMed ID: 28000877
    [Abstract] [Full Text] [Related]

  • 8. A bone-resorption surface-targeting nanoparticle to deliver anti-miR214 for osteoporosis therapy.
    Cai M, Yang L, Zhang S, Liu J, Sun Y, Wang X.
    Int J Nanomedicine; 2017 Feb 13; 12():7469-7482. PubMed ID: 29075114
    [Abstract] [Full Text] [Related]

  • 9. Ebselen Is a Potential Anti-Osteoporosis Agent by Suppressing Receptor Activator of Nuclear Factor Kappa-B Ligand-Induced Osteoclast Differentiation In vitro and Lipopolysaccharide-Induced Inflammatory Bone Destruction In vivo.
    Baek JM, Kim JY, Yoon KH, Oh J, Lee MS.
    Int J Biol Sci; 2016 Feb 13; 12(5):478-88. PubMed ID: 27019631
    [Abstract] [Full Text] [Related]

  • 10. Natural Compounds for Bone Remodeling: A Computational and Experimental Approach Targeting Bone Metabolism-Related Proteins.
    Loukas AT, Papadourakis M, Panagiotopoulos V, Zarmpala A, Chontzopoulou E, Christodoulou S, Katsila T, Zoumpoulakis P, Matsoukas MT.
    Int J Mol Sci; 2024 May 06; 25(9):. PubMed ID: 38732267
    [Abstract] [Full Text] [Related]

  • 11. Natural products for treatment of osteoporosis: The effects and mechanisms on promoting osteoblast-mediated bone formation.
    An J, Yang H, Zhang Q, Liu C, Zhao J, Zhang L, Chen B.
    Life Sci; 2016 Feb 15; 147():46-58. PubMed ID: 26796578
    [Abstract] [Full Text] [Related]

  • 12. Glycyrrhizic acid suppresses osteoclast differentiation and postmenopausal osteoporosis by modulating the NF-κB, ERK, and JNK signaling pathways.
    Yin Z, Zhu W, Wu Q, Zhang Q, Guo S, Liu T, Li S, Chen X, Peng D, Ouyang Z.
    Eur J Pharmacol; 2019 Sep 15; 859():172550. PubMed ID: 31323222
    [Abstract] [Full Text] [Related]

  • 13. Psoralidin, a prenylated coumestan, as a novel anti-osteoporosis candidate to enhance bone formation of osteoblasts and decrease bone resorption of osteoclasts.
    Zhai Y, Li Y, Wang Y, Cui J, Feng K, Kong X, Chen L.
    Eur J Pharmacol; 2017 Apr 15; 801():62-71. PubMed ID: 28283388
    [Abstract] [Full Text] [Related]

  • 14. Epigenetic Regulators Involved in Osteoclast Differentiation.
    Astleford K, Campbell E, Norton A, Mansky KC.
    Int J Mol Sci; 2020 Sep 25; 21(19):. PubMed ID: 32992908
    [Abstract] [Full Text] [Related]

  • 15. Bisphosphonate-enoxacin inhibit osteoclast formation and function by abrogating RANKL-induced JNK signalling pathways during osteoporosis treatment.
    Xu Q, Zhan P, Li X, Mo F, Xu H, Liu Y, Lai Q, Zhang B, Dai M, Liu X.
    J Cell Mol Med; 2021 Nov 25; 25(21):10126-10139. PubMed ID: 34651433
    [Abstract] [Full Text] [Related]

  • 16. Effects of a traditional Chinese herbal preparation on osteoblasts and osteoclasts.
    Zhang H, Xing WW, Li YS, Zhu Z, Wu JZ, Zhang QY, Zhang W, Qin LP.
    Maturitas; 2008 Dec 20; 61(4):334-9. PubMed ID: 19004583
    [Abstract] [Full Text] [Related]

  • 17. Macrolactin A protects against LPS-induced bone loss by regulation of bone remodeling.
    Sapkota M, Gao M, Li L, Yang M, Shrestha SK, Choi H, Soh Y.
    Eur J Pharmacol; 2020 Sep 15; 883():173305. PubMed ID: 32673673
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Herba epimedii flavonoids suppress osteoclastic differentiation and bone resorption by inducing G2/M arrest and apoptosis.
    Zhang D, Zhang J, Fong C, Yao X, Yang M.
    Biochimie; 2012 Dec 15; 94(12):2514-22. PubMed ID: 22796380
    [Abstract] [Full Text] [Related]

  • 20. YC-1 alleviates bone loss in ovariectomized rats by inhibiting bone resorption and inducing extrinsic apoptosis in osteoclasts.
    Wang JW, Yeh CB, Chou SJ, Lu KC, Chu TH, Chen WY, Chien JL, Yen MH, Chen TH, Shyu JF.
    J Bone Miner Metab; 2018 Sep 15; 36(5):508-518. PubMed ID: 28983668
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.